Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Dr. Kathryn Quadracci FloresDirector | -27,43k | 200,27k | Sale to Issuer | 7,25 - 7,40 | 16,73k | -62,12% |
| 2026-05-01 | Ms. Beth-Ann EasonIndependent Director | -30,74k | 254,51k | Sale to Issuer | 8,28 | 67,14k | -31,40% |
| 2026-05-01 | Dr. Kathryn Quadracci FloresDirector | -7,68k | 63,70k | Sale to Issuer | 8,30 | 94,76k | -7,49% |
| 2026-03-06 | Dr. Kathryn Quadracci FloresDirector | -10,66k | 70,88k | Sale to Issuer | 6,65 | 44,15k | -19,44% |
| 2026-03-01 | Mr. J. Joel QuadracciChairman & CEO | -176,54k | 1,22M | Sale to Issuer | 6,91 | 2,43M | -6,78% |
| 2026-03-01 | Mr. David J. HonanPresident & COO | -73,56k | 508,28k | Sale to Issuer | 6,91 | 749,32k | -8,94% |
| 2026-03-01 | Robert H. QuadracciInitié | -7,75k | 53,52k | Sale to Issuer | 6,91 | 167,33k | -4,42% |
| 2026-03-01 | Ms. Dana B. GruenChief Risk & Compliance Officer, General Counsel and Corporate Secretary | -19,20k | 132,69k | Sale to Issuer | 6,91 | 198,28k | -8,83% |
| 2026-03-01 | Dr. Kathryn Quadracci FloresDirector | -7,23k | 49,97k | Sale to Issuer | 6,91 | 54,81k | -11,66% |
| 2026-03-01 | Ms. Julie A. CurrieExec. VP & Chief Revenue Officer | -13,10k | 90,53k | Sale to Issuer | 6,91 | 175,64k | -6,94% |
| 2026-03-01 | Mr. Kelly A. VanderboomExec. VP and Head of QAS Operations & Logistics | -25,41k | 175,56k | Sale to Issuer | 6,91 | 321,39k | -7,33% |
| 2026-03-01 | Mr. Anthony C. StaniakCFO & Treasurer | -21,46k | 148,31k | Sale to Issuer | 6,91 | 388,12k | -5,24% |
| 2026-03-01 | Mr. Donald M. McKennaExec. VP & Chief Administrative Officer | -20,12k | 139,04k | Sale to Issuer | 6,91 | 175,62k | -10,28% |
| 2026-03-01 | Mr. Steven D. JaegerVP & Chief Information Officer | -18,63k | 128,15k | Sale to Issuer | 6,84 - 6,91 | 130,15k | -12,52% |
| 2026-03-01 | Ms. Anne M. BauerVP & CAO | -5,53k | 38,18k | Sale to Issuer | 6,91 | 53,62k | -9,34% |
| 2026-02-23 | Mr. Douglas Paul ButhIndependent Director | -20,00k | 140,43k | Sale to Issuer | 7,02 | 96,16k | -17,22% |
| 2026-02-20 | Mr. Donald M. McKennaExec. VP & Chief Administrative Officer | -7,93k | 55,73k | Sale to Issuer | 7,03 | 195,74k | -3,89% |
| 2026-02-20 | Dr. Kathryn Quadracci FloresDirector | -11,63k | 78,41k | Sale to Issuer | 6,74 | 62,04k | -15,79% |
| 2025-11-20 | Mr. Joshua J. GoldenInitié | -18,39k | 97,83k | Sale to Issuer | 5,32 | 114,88k | -13,80% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
